May 16, 2008
Avastin improves brain cancer survival
“Avastin, both as a single agent and in combination with irinotecan chemotherapy, may improve survival compared to what would be normally expected for this devastating disease”
Results from a mid-stage trial showed treatment with Genentech Inc's Avastin improved survival for patients with recurring brain cancer, the company said on Thursday. via Reuters
Read full story from Reuters
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Vioxx claimants rush to join $4.85B settlement ... (from Jan '08) | 4 min | Dick In Ohio | 685 |
| Claims administrator: Interim payments in $4.85... | 7 min | Dick In Ohio | 1049 |
| MPI Research cutting jobs in Mattawan | 6 hr | Former MPI E... | 18 |
| Cymbalta leads the way for Lilly (from Feb '07) | 6 hr | Stranger In ... | 234 |
| Merck to fund Vioxx settlement in August | 8 hr | Peggy | 1375 |
| Northwestern Memorial Hospital patient's compla... | 9 hr | Old RN | 2 |
| Johnson & Johnson buying Mentor for $1.07B | 11 hr | Anon Amous | 3 |
Gemini
Most Popular